Literature DB >> 18095841

Predictors of the initiation of HIV postexposure prophylaxis in Rhode Island emergency departments.

Roland C Merchant1, Kenneth H Mayer, Bruce M Becker, Allison K Delong, Joseph W Hogan.   

Abstract

The objective of this study was to elucidate factors that predicted the initiation of HIV postexposure prophylaxis (PEP) for blood or body fluid exposures evaluated at Rhode Island emergency departments (EDs). The study involved a retrospective review of patient visits to all civilian Rhode Island EDs for these exposures from 1995 to mid-2001. Multivariate logistic regression models were created to evaluate predictors of the offering and the acceptance and receipt of HIV PEP from 1996 to 2001. The search identified 3622 patients who sustained a blood or body fluid exposure. Of these, 43.8% were health care workers (HCWs) and 57.2% were not HCWs. Most (52.0%) of the exposures were nonsexual. HIV PEP was offered to 21.0% and accepted and received by 9.4% of all patients. HIV PEP was offered more often after significant exposures, exposures to known HIV-infected sources, when time elapsed after the exposure was shorter, if the patients were HCWs, adults, presented to a teaching hospital, presented during the latter years of the study, or sustained nonsexual exposures. Once offered HIV PEP, patients who were male, adult, sustained a significant exposure, knew the source was HIV infected, sustained a nonsexual exposure, or were HCWs had a greater odds of accepting and receiving HIV PEP. Even when controlling for exposure significance, HIV status, and time elapsed since the exposure, several factors such as gender and type of hospital that are unrelated to the exposure appeared to influence the initiation of HIV PEP. ED providers should ensure that these factors do not inappropriately restrict its initiation.

Entities:  

Mesh:

Year:  2008        PMID: 18095841      PMCID: PMC3206608          DOI: 10.1089/apc.2007.0031

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  31 in total

1.  Out of hours management of occupational exposures to blood and body fluids in healthcare staff.

Authors:  D Patel; M Gawthrop; D Snashall; I Madan
Journal:  Occup Environ Med       Date:  2002-06       Impact factor: 4.402

2.  Nonoccupational postexposure HIV prevention: emergency physicians' current practices, attitudes, and beliefs.

Authors:  Julie B McCausland; Judith A Linden; Linda C Degutis; Prasanthi Ramanujam; Lisa M Sullivan; Gail D'onofrio
Journal:  Ann Emerg Med       Date:  2003-11       Impact factor: 5.721

3.  Community acquired needlestick injuries in non-health care workers presenting to an urban emergency department.

Authors:  Fenton M O'Leary; Timothy C Green
Journal:  Emerg Med (Fremantle)       Date:  2003 Oct-Dec

4.  Prophylaxis provided to sexual assault victims seen at US emergency departments.

Authors:  Sue Rovi; Noa'a Shimoni
Journal:  J Am Med Womens Assoc (1972)       Date:  2002

5.  [Reducing the risk of blood-transmitted infections of HIV, hepatitis B or C virus in a teaching hospital in Amsterdam--evaluation of a protocol for needlestick accidents among hospital staff during the period 1997-2001].

Authors:  R M Regez; P J G M Rietra; C Th M van der Linden; P H J Frissen; H M Weigel; K Brinkman
Journal:  Ned Tijdschr Geneeskd       Date:  2002-03-30

6.  Post-exposure prophylaxis for human immunodeficiency virus infection in the Royal Infirmary of Edinburgh--an audit.

Authors:  K Manavi; A McMillan; J Paterson
Journal:  Int J STD AIDS       Date:  2004-02       Impact factor: 1.359

7.  Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-06-07       Impact factor: 17.586

8.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

9.  HIV postexposure prophylaxis practices by US ED practitioners.

Authors:  Roland C Merchant; Reza Keshavarz
Journal:  Am J Emerg Med       Date:  2003-07       Impact factor: 2.469

10.  Emergency department blood or body fluid exposure evaluations and HIV postexposure prophylaxis usage.

Authors:  Roland C Merchant; Bruce M Becker; Kenneth H Mayer; Janene Fuerch; Barbara Schreck
Journal:  Acad Emerg Med       Date:  2003-12       Impact factor: 3.451

View more
  4 in total

1.  A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV.

Authors:  Michelle E Roland; Torsten B Neilands; Melissa R Krone; Thomas J Coates; Karena Franses; Margaret A Chesney; James S Kahn; Jeffrey N Martin
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

2.  Efficiency of International Classification of Diseases, Ninth Revision, billing code searches to identify emergency department visits for blood or body fluid exposures through a statewide multicenter database.

Authors:  Lisa M Rosen; Tao Liu; Roland C Merchant
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04-12       Impact factor: 3.254

3.  HIV prescriptions on the frontlines: Primary care providers' use of antiretrovirals for prevention in the Southeast United States, 2017.

Authors:  Kirk D Henny; Christopher C Duke; Kate Buchacz; John T Brooks; Taraz Samandari; Madeline Y Sutton
Journal:  Prev Med       Date:  2019-10-31       Impact factor: 4.018

4.  Self-reported occupational exposure to HIV and factors influencing its management practice: a study of healthcare workers in Tumbi and Dodoma Hospitals, Tanzania.

Authors:  Kijakazi O Mashoto; Godfrey M Mubyazi; Hussein Mohamed; Hamisi M Malebo
Journal:  BMC Health Serv Res       Date:  2013-07-17       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.